“The billionaire’s pandemic investments, like much of his work, remain a secret.” [Source: thenation.com]
As this article describes, the Bill & Melinda Gates Foundation’s priorities in developing and distributing a Covid vaccine are increasingly becoming the world’s priorities. This is because global institutions such as the World Health Organization (WHO) have essentially ceded their leadership to a group of public-private partnerships that are massively funded by the Gates Foundation. These organizations, which include the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance, are working with the WHO to develop what they say is “the largest and most diverse Covid-19 vaccine portfolio in the world.”
As one of the world’s most influential voices in the global pandemic response, the Gates Foundation is therefore in a position to potentially reap considerable financial gains from the Covid pandemic. Already, for example, in a period spanning less than two years, it has managed to turn a $55 million investment in BioNTech, the developer of the Pfizer mRNA vaccine, into over $550 million.
But BioNtech is hardly the only Covid-19 vaccine maker the Gates Foundation has invested in, as it has reportedly also bought shares in Pfizer, CureVac, and Vir Biotechnology. Significantly, therefore, many of its senior staff are said to come from the drug industry. Seen in this light it is thus hardly surprising that the Gates Foundation uses its enormous wealth to furtively reinforce the pharmaceutical status quo. While Gates has admitted to the New England Journal of Medicine that his conflicts of interest are “numerous,” transparency over the broader details of his organization’s activities, such as the contracts it signs, is distinctly lacking.
To read how the Gates Foundation has become one of the largest funders of the WHO, see this article on our website.